Skip to main content

Welcome

We provide news, expert interviews, and educational resources to help you keep up with the latest developments in diabetes

News

EXPECT: Degludec noninferior to detemir in pregnancy for type 1 diabetes

Pregnant women with type 1 diabetes can achieve similar glucose control regardless of whether they use insulin degludec or detemir, show the results of the randomised EXPECT trial.

Content hub

The challenge of type 2 diabetes in children

Who is at the highest risk for developing type 2 diabetes in their youth? What are the consequences of being diagnosed so young, and what can clinicians do to help? Browse the hub to find out

Hot topic review

How far has immunotherapy for type 1 diabetes progressed?

Read our Hot Topic Review for a rapid update on the successes and failures of immunotherapies in people with or at high risk for type 1 diabetes.

View from the clinic

Managing hyperglycemia in the face of a high-carbohydrate diet

Sanjay Kalra considers the course of action when blood glucose remains high in someone who cannot, or will not, modify a high-carbohydrate diet. Read more

Initiating GLP-1 receptor agonists: Managing side effects

Specialist nurse Nicola Milne discusses the side effects that can arise in people with type 2 diabetes during initiation of GLP-1 receptor agonists, and how to best manage them.

IN FOCUS | GLP-1 receptor agonists

Syringe and pills

11-01-2022 | SGLT2 inhibitors | News

Real-world adjunctive medication outcomes in type 1 diabetes revealed

People with type 1 diabetes who take GLP-1 receptor agonists or SGLT2 inhibitors in clinical practice have outcomes that are mostly – but not all – in line with those in controlled trials, say researchers.

IN FOCUS | Hypoglycemia

Senior man with glucometer checking blood sugar

11-29-2022 | Older adults | News

Call to rethink CGM advice for older adults

Analysis of participants in the ORACL trial leads researchers to suggest that nonfrail older adults with type 1 diabetes are better off following time in range guidance aimed at younger people.

IN FOCUS | Cardiovascular disorders

Human heart with ecg graph. 3d illustration

11-18-2022 | Dapagliflozin | News

Dapagliflozin HFpEF benefits independent of glucose levels

People who have heart failure with preserved ejection fraction benefit from dapagliflozin irrespective of whether they have normal or impaired glucose metabolism, shows further analysis of DELIVER.

IN FOCUS | Kidney disease

Close up of urinalysis with reagent strips

11-10-2022 | Nephropathy | News

‘Strong justification’ for individualized albuminuria screening in type 1 diabetes

Screening people with type 1 diabetes for albuminuria at intervals determined by their baseline albumin excretion rate and glycated hemoglobin level reduces the time spent with undetected kidney disease, show DCCT/EDIC data.

Stay informed with Medicine Matters

Get the latest developments in diabetes delivered straight to your inbox

IN FOCUS | Diabetes devices & technology

Senior man with glucometer checking blood sugar

11-29-2022 | Older adults | News

Call to rethink CGM advice for older adults

Analysis of participants in the ORACL trial leads researchers to suggest that nonfrail older adults with type 1 diabetes are better off following time in range guidance aimed at younger people.

IN FOCUS | Obesity & lifestyle interventions

Syringe and pills

11-01-2022 | SGLT2 inhibitors | News

Real-world adjunctive medication outcomes in type 1 diabetes revealed

People with type 1 diabetes who take GLP-1 receptor agonists or SGLT2 inhibitors in clinical practice have outcomes that are mostly – but not all – in line with those in controlled trials, say researchers.

IN FOCUS | SGLT2 inhibitors

Close up of mixed medications

12-09-2022 | Medications | News

TriMaster data support ‘try before you choose’ for type 2 diabetes medications

Allowing people to try out medications for type 2 diabetes and choose their preferred one is a viable approach in the absence of a clear clinical indication, say the TriMaster investigators.

IN FOCUS | Hyperglycemia

X-ray of fractured forearm shaft of radius and ulnar bone on red mark

05-24-2022 | Bone health | News

Poor glycemic control, kidney disease linked to bone fragility in type 1 diabetes

Higher glycated hemoglobin and the presence of kidney disease are associated with lower bone mineral density in people with type 1 diabetes, study results show.

IN FOCUS | Pediatric type 2 diabetes

Weekly pill container

04-04-2022 | Dapagliflozin | News

Phase 3 trial supports dapagliflozin in young people with type 2 diabetes

The first phase 3 trial of an SGLT2 inhibitor in children and young people with type 2 diabetes shows that dapagliflozin significantly improves their glucose control – as long as they remember to take it.

IN FOCUS | Tirzepatide

Person standing on weigh scales with tape measure in foreground

06-04-2022 | ADA 2022 | Conference coverage | News

​​​​​​​SURMOUNT-1 places tirzepatide weight loss efficacy within surgical range

A weekly injection of tirzepatide results in a substantial bodyweight reduction over and above that achieved with lifestyle intervention in people with obesity, show the SURMOUNT-1 findings.

IN FOCUS | Mental health & psychosocial care

Lori Berard

04-14-2022 | Hyperglycemia | View from the clinic | Article

Managing hyperglycemia related to stress

Lori Berard highlights the contribution of stress to poor glycemic control and considers how healthcare providers can account for this in their practice.